Marco Milán (Development and Growth Control Lab) interviewed in Catalunya Ràdio about the uses of Drosophila melanogaster for biomedical reseacher. IRB Barcelona is a pioneer in the use of flies to study human conditions like cancer and genetic diseases.
Several media echo on the research lead by Ernest Giralt focused on the use of wasp venom as a strategy to kill cancer cells selectively.
News of the Spanish Scientific News Agency, SINC Agency, on a study perfomed at Ernest Giralt's lab with wasp venom to desing a new therapyagainst breast cancer.
The laboratory of Peptides and Proteins, headed by Ernest Giralt , published in the Journal of Controlled Released a therapy for breast cancer using the wasp venom. The August magazine of “Muy Interesante” has echoed the study.
The Pharma Boardroom is the premier website for senior executives, consultants, regulators and vendors working in Healthcare Life Sciences globally. Pharma Boardroom published today an interview with Joan Guinovart, the director of the IRB Barcelona. In it he discusses the Institute’s unique interdisciplinary characteristics and emphasizes the need for Spain to foster technology transfer as a means to further innovation.
More cash and many profound structural changes—according to a panel of European experts, is what Spain's national science and innovation system needs to become more competitive. “The good news for the Spanish government is that even in a crisis context, these reforms can be done,” says Joan Guinovart, director of the IRB Barcelona, in the Science magazine. “No more words are needed, now … is the time to apply the recommendations.”
Diario Médico echoes on an article about nutrition developed by Lara Barrio and Marco Milán in the Development and Growth Control laboratory. The work was published in Cell Reports.
Article about the situation of the biomedical research in Catalonia in the international section of the Catalan News Agency (CNA). The article highlights the high level of the research performed in Catalonia as well as the total volume of publications, 10 times higher from the volume expected by population. Among the consulted sources, there is the director of the IRB Barcelona, Joan Guinovart.
El Punt-Avui TV interwiews Natàlia Carulla, organizer of the Barcelona Biomed Conference about Alzheimer’s disease, held from 9 to 11 of July in Barcelona. The IRB researcher, explains the current state of the research against Alzheimer’s disease and exposes the need for more resources in research to find a cure.
Interview with the Nobel prize Tim Hunt published in Science that the correspondent of Science Carrers in Barcelona, Elisabeth Pain, did during the first IRB Barcelona PostDoc Day. Hunt gave the plenary session of the postdoctoral researchers session. Hunt, who won the Nobel Prize in 2001 for the discovery of cyclins, expose which are the key points that led him to success during his scientific career.